Industry Research Reports
Global Spine Biologics Market Research Report 2025
Industry: Medical Devices & Consumables
Published Date: 2025-01-16
Pages: 91 Pages
Report ld: 3466234
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Spine Biologics Market Size(US$)
CAGR 2025-2031
3.3%
Market Size,2031
USD 3,153
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 2,595 million
Market Forecast in 2031(Value)
US$ 3,153 million
CAGR
3.3%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Spine Biologics was valued at US$ 2520 million in the year 2024 and is projected to reach a revised size of US$ 3153 million by 2031, growing at a CAGR of 3.3% during the forecast period.
Spine biologics are used in spine surgery as lieu allografts and as support for bones in and around the spinal region. They can also be used as products that can cure the spine injuries or disorders or degenerated discs.
Global Spine Biologics key players include Medtronic, Depuy Synthes, Stryker Corporation, Nuvasive, Zimmer Biomet, etc. Global top five manufacturers hold a share over 75%.
North America is the largest market, with a share over 60%, followed by Europe and Asia (Ex. China), both have a share about 30%.
In terms of product, Bone Graft is the largest segment, with a share over 55%. And in terms of application, the largest application is Posterior Lumbar Interbody Fusion, followed by Anterior Cervical Discectomy and Fusion, etc.
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Spine Biologics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Spine Biologics.
The Spine Biologics market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Spine Biologics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Spine Biologics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Medtronic
Depuy Synthes
Stryker Corporation
Nuvasive
Zimmer Biomet
Orthofix International
Globus Medical
alphatec spine
K2M
Exactech
Wright Medical Technology
X-Spine
Nutech
Arthrex
Segment by Type
Bone Graft
Bone Graft Substitute
Platelet Rich Plasma (PRP)
BMAC (Bone Marrow Aspirate Concentrate)
Segment by Application
Anterior Cervical Discectomy and Fusion
Posterior Lumbar Interbody Fusion
Others
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Spine Biologics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Spine Biologics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Spine Biologics Market Overview
1.1 Product Definition
1.2 Spine Biologics by Type
1.2.1 Global Spine Biologics Market Value Comparison by Type (2024 VS 2031)
1.2.2 Bone Graft
1.2.3 Bone Graft Substitute
1.2.4 Platelet Rich Plasma (PRP)
1.2.5 BMAC (Bone Marrow Aspirate Concentrate)
1.3 Spine Biologics by Application
1.3.1 Global Spine Biologics Market Value by Application (2024 VS 2031)
1.3.2 Anterior Cervical Discectomy and Fusion
1.3.3 Posterior Lumbar Interbody Fusion
1.3.4 Others
1.4 Global Spine Biologics Market Size Estimates and Forecasts
1.4.1 Global Spine Biologics Revenue 2020-2031
1.4.2 Global Spine Biologics Sales 2020-2031
1.4.3 Global Spine Biologics Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Spine Biologics Market Competition by Manufacturers
2.1 Global Spine Biologics Sales Market Share by Manufacturers (2020-2025)
2.2 Global Spine Biologics Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Spine Biologics Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Spine Biologics, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Spine Biologics, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Spine Biologics, Product Type & Application
2.7 Global Key Manufacturers of Spine Biologics, Date of Enter into This Industry
2.8 Global Spine Biologics Market Competitive Situation and Trends
2.8.1 Global Spine Biologics Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Spine Biologics Players Market Share by Revenue
2.8.3 Global Spine Biologics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Spine Biologics Market Scenario by Region
3.1 Global Spine Biologics Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Spine Biologics Sales by Region: 2020-2031
3.2.1 Global Spine Biologics Sales by Region: 2020-2025
3.2.2 Global Spine Biologics Sales by Region: 2026-2031
3.3 Global Spine Biologics Revenue by Region: 2020-2031
3.3.1 Global Spine Biologics Revenue by Region: 2020-2025
3.3.2 Global Spine Biologics Revenue by Region: 2026-2031
3.4 North America Spine Biologics Market Facts & Figures by Country
3.4.1 North America Spine Biologics Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Spine Biologics Sales by Country (2020-2031)
3.4.3 North America Spine Biologics Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Spine Biologics Market Facts & Figures by Country
3.5.1 Europe Spine Biologics Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Spine Biologics Sales by Country (2020-2031)
3.5.3 Europe Spine Biologics Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Spine Biologics Market Facts & Figures by Region
3.6.1 Asia Pacific Spine Biologics Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Spine Biologics Sales by Region (2020-2031)
3.6.3 Asia Pacific Spine Biologics Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Spine Biologics Market Facts & Figures by Country
3.7.1 Latin America Spine Biologics Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Spine Biologics Sales by Country (2020-2031)
3.7.3 Latin America Spine Biologics Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Spine Biologics Market Facts & Figures by Country
3.8.1 Middle East and Africa Spine Biologics Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Spine Biologics Sales by Country (2020-2031)
3.8.3 Middle East and Africa Spine Biologics Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Spine Biologics Sales by Type (2020-2031)
4.1.1 Global Spine Biologics Sales by Type (2020-2025)
4.1.2 Global Spine Biologics Sales by Type (2026-2031)
4.1.3 Global Spine Biologics Sales Market Share by Type (2020-2031)
4.2 Global Spine Biologics Revenue by Type (2020-2031)
4.2.1 Global Spine Biologics Revenue by Type (2020-2025)
4.2.2 Global Spine Biologics Revenue by Type (2026-2031)
4.2.3 Global Spine Biologics Revenue Market Share by Type (2020-2031)
4.3 Global Spine Biologics Price by Type (2020-2031)
5 Segment by Application
5.1 Global Spine Biologics Sales by Application (2020-2031)
5.1.1 Global Spine Biologics Sales by Application (2020-2025)
5.1.2 Global Spine Biologics Sales by Application (2026-2031)
5.1.3 Global Spine Biologics Sales Market Share by Application (2020-2031)
5.2 Global Spine Biologics Revenue by Application (2020-2031)
5.2.1 Global Spine Biologics Revenue by Application (2020-2025)
5.2.2 Global Spine Biologics Revenue by Application (2026-2031)
5.2.3 Global Spine Biologics Revenue Market Share by Application (2020-2031)
5.3 Global Spine Biologics Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Medtronic
6.1.1 Medtronic Company Information
6.1.2 Medtronic Description and Business Overview
6.1.3 Medtronic Spine Biologics Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Medtronic Spine Biologics Product Portfolio
6.1.5 Medtronic Recent Developments/Updates
6.2 Depuy Synthes
6.2.1 Depuy Synthes Company Information
6.2.2 Depuy Synthes Description and Business Overview
6.2.3 Depuy Synthes Spine Biologics Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Depuy Synthes Spine Biologics Product Portfolio
6.2.5 Depuy Synthes Recent Developments/Updates
6.3 Stryker Corporation
6.3.1 Stryker Corporation Company Information
6.3.2 Stryker Corporation Description and Business Overview
6.3.3 Stryker Corporation Spine Biologics Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Stryker Corporation Spine Biologics Product Portfolio
6.3.5 Stryker Corporation Recent Developments/Updates
6.4 Nuvasive
6.4.1 Nuvasive Company Information
6.4.2 Nuvasive Description and Business Overview
6.4.3 Nuvasive Spine Biologics Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Nuvasive Spine Biologics Product Portfolio
6.4.5 Nuvasive Recent Developments/Updates
6.5 Zimmer Biomet
6.5.1 Zimmer Biomet Company Information
6.5.2 Zimmer Biomet Description and Business Overview
6.5.3 Zimmer Biomet Spine Biologics Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Zimmer Biomet Spine Biologics Product Portfolio
6.5.5 Zimmer Biomet Recent Developments/Updates
6.6 Orthofix International
6.6.1 Orthofix International Company Information
6.6.2 Orthofix International Description and Business Overview
6.6.3 Orthofix International Spine Biologics Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Orthofix International Spine Biologics Product Portfolio
6.6.5 Orthofix International Recent Developments/Updates
6.7 Globus Medical
6.7.1 Globus Medical Company Information
6.7.2 Globus Medical Description and Business Overview
6.7.3 Globus Medical Spine Biologics Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Globus Medical Spine Biologics Product Portfolio
6.7.5 Globus Medical Recent Developments/Updates
6.8 alphatec spine
6.8.1 alphatec spine Company Information
6.8.2 alphatec spine Description and Business Overview
6.8.3 alphatec spine Spine Biologics Sales, Revenue and Gross Margin (2020-2025)
6.8.4 alphatec spine Spine Biologics Product Portfolio
6.8.5 alphatec spine Recent Developments/Updates
6.9 K2M
6.9.1 K2M Company Information
6.9.2 K2M Description and Business Overview
6.9.3 K2M Spine Biologics Sales, Revenue and Gross Margin (2020-2025)
6.9.4 K2M Spine Biologics Product Portfolio
6.9.5 K2M Recent Developments/Updates
6.10 Exactech
6.10.1 Exactech Company Information
6.10.2 Exactech Description and Business Overview
6.10.3 Exactech Spine Biologics Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Exactech Spine Biologics Product Portfolio
6.10.5 Exactech Recent Developments/Updates
6.11 Wright Medical Technology
6.11.1 Wright Medical Technology Company Information
6.11.2 Wright Medical Technology Description and Business Overview
6.11.3 Wright Medical Technology Spine Biologics Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Wright Medical Technology Spine Biologics Product Portfolio
6.11.5 Wright Medical Technology Recent Developments/Updates
6.12 X-Spine
6.12.1 X-Spine Company Information
6.12.2 X-Spine Description and Business Overview
6.12.3 X-Spine Spine Biologics Sales, Revenue and Gross Margin (2020-2025)
6.12.4 X-Spine Spine Biologics Product Portfolio
6.12.5 X-Spine Recent Developments/Updates
6.13 Nutech
6.13.1 Nutech Company Information
6.13.2 Nutech Description and Business Overview
6.13.3 Nutech Spine Biologics Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Nutech Spine Biologics Product Portfolio
6.13.5 Nutech Recent Developments/Updates
6.14 Arthrex
6.14.1 Arthrex Company Information
6.14.2 Arthrex Description and Business Overview
6.14.3 Arthrex Spine Biologics Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Arthrex Spine Biologics Product Portfolio
6.14.5 Arthrex Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Spine Biologics Industry Chain Analysis
7.2 Spine Biologics Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Spine Biologics Production Mode & Process Analysis
7.4 Spine Biologics Sales and Marketing
7.4.1 Spine Biologics Sales Channels
7.4.2 Spine Biologics Distributors
7.5 Spine Biologics Customer Analysis
8 Spine Biologics Market Dynamics
8.1 Spine Biologics Industry Trends
8.2 Spine Biologics Market Drivers
8.3 Spine Biologics Market Challenges
8.4 Spine Biologics Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Spine Biologics Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Spine Biologics Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Spine Biologics Market Competitive Situation by Manufacturers in 2024
Table 4. Global Spine Biologics Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Spine Biologics Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Spine Biologics Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Spine Biologics Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Spine Biologics Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Spine Biologics, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Spine Biologics, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Spine Biologics, Product Type & Application
Table 12. Global Key Manufacturers of Spine Biologics, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Spine Biologics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Spine Biologics as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Spine Biologics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Spine Biologics Sales by Region (2020-2025) & (K Units)
Table 18. Global Spine Biologics Sales Market Share by Region (2020-2025)
Table 19. Global Spine Biologics Sales by Region (2026-2031) & (K Units)
Table 20. Global Spine Biologics Sales Market Share by Region (2026-2031)
Table 21. Global Spine Biologics Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Spine Biologics Revenue Market Share by Region (2020-2025)
Table 23. Global Spine Biologics Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Spine Biologics Revenue Market Share by Region (2026-2031)
Table 25. North America Spine Biologics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Spine Biologics Sales by Country (2020-2025) & (K Units)
Table 27. North America Spine Biologics Sales by Country (2026-2031) & (K Units)
Table 28. North America Spine Biologics Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Spine Biologics Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Spine Biologics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Spine Biologics Sales by Country (2020-2025) & (K Units)
Table 32. Europe Spine Biologics Sales by Country (2026-2031) & (K Units)
Table 33. Europe Spine Biologics Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Spine Biologics Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Spine Biologics Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Spine Biologics Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Spine Biologics Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Spine Biologics Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Spine Biologics Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Spine Biologics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Spine Biologics Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Spine Biologics Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Spine Biologics Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Spine Biologics Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Spine Biologics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Spine Biologics Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Spine Biologics Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Spine Biologics Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Spine Biologics Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Spine Biologics Sales (K Units) by Type (2020-2025)
Table 51. Global Spine Biologics Sales (K Units) by Type (2026-2031)
Table 52. Global Spine Biologics Sales Market Share by Type (2020-2025)
Table 53. Global Spine Biologics Sales Market Share by Type (2026-2031)
Table 54. Global Spine Biologics Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Spine Biologics Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Spine Biologics Revenue Market Share by Type (2020-2025)
Table 57. Global Spine Biologics Revenue Market Share by Type (2026-2031)
Table 58. Global Spine Biologics Price (USD/Unit) by Type (2020-2025)
Table 59. Global Spine Biologics Price (USD/Unit) by Type (2026-2031)
Table 60. Global Spine Biologics Sales (K Units) by Application (2020-2025)
Table 61. Global Spine Biologics Sales (K Units) by Application (2026-2031)
Table 62. Global Spine Biologics Sales Market Share by Application (2020-2025)
Table 63. Global Spine Biologics Sales Market Share by Application (2026-2031)
Table 64. Global Spine Biologics Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Spine Biologics Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Spine Biologics Revenue Market Share by Application (2020-2025)
Table 67. Global Spine Biologics Revenue Market Share by Application (2026-2031)
Table 68. Global Spine Biologics Price (USD/Unit) by Application (2020-2025)
Table 69. Global Spine Biologics Price (USD/Unit) by Application (2026-2031)
Table 70. Medtronic Company Information
Table 71. Medtronic Description and Business Overview
Table 72. Medtronic Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 73. Medtronic Spine Biologics Product
Table 74. Medtronic Recent Developments/Updates
Table 75. Depuy Synthes Company Information
Table 76. Depuy Synthes Description and Business Overview
Table 77. Depuy Synthes Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78. Depuy Synthes Spine Biologics Product
Table 79. Depuy Synthes Recent Developments/Updates
Table 80. Stryker Corporation Company Information
Table 81. Stryker Corporation Description and Business Overview
Table 82. Stryker Corporation Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Stryker Corporation Spine Biologics Product
Table 84. Stryker Corporation Recent Developments/Updates
Table 85. Nuvasive Company Information
Table 86. Nuvasive Description and Business Overview
Table 87. Nuvasive Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Nuvasive Spine Biologics Product
Table 89. Nuvasive Recent Developments/Updates
Table 90. Zimmer Biomet Company Information
Table 91. Zimmer Biomet Description and Business Overview
Table 92. Zimmer Biomet Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Zimmer Biomet Spine Biologics Product
Table 94. Zimmer Biomet Recent Developments/Updates
Table 95. Orthofix International Company Information
Table 96. Orthofix International Description and Business Overview
Table 97. Orthofix International Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Orthofix International Spine Biologics Product
Table 99. Orthofix International Recent Developments/Updates
Table 100. Globus Medical Company Information
Table 101. Globus Medical Description and Business Overview
Table 102. Globus Medical Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Globus Medical Spine Biologics Product
Table 104. Globus Medical Recent Developments/Updates
Table 105. alphatec spine Company Information
Table 106. alphatec spine Description and Business Overview
Table 107. alphatec spine Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. alphatec spine Spine Biologics Product
Table 109. alphatec spine Recent Developments/Updates
Table 110. K2M Company Information
Table 111. K2M Description and Business Overview
Table 112. K2M Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. K2M Spine Biologics Product
Table 114. K2M Recent Developments/Updates
Table 115. Exactech Company Information
Table 116. Exactech Description and Business Overview
Table 117. Exactech Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Exactech Spine Biologics Product
Table 119. Exactech Recent Developments/Updates
Table 120. Wright Medical Technology Company Information
Table 121. Wright Medical Technology Description and Business Overview
Table 122. Wright Medical Technology Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Wright Medical Technology Spine Biologics Product
Table 124. Wright Medical Technology Recent Developments/Updates
Table 125. X-Spine Company Information
Table 126. X-Spine Description and Business Overview
Table 127. X-Spine Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. X-Spine Spine Biologics Product
Table 129. X-Spine Recent Developments/Updates
Table 130. Nutech Company Information
Table 131. Nutech Description and Business Overview
Table 132. Nutech Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. Nutech Spine Biologics Product
Table 134. Nutech Recent Developments/Updates
Table 135. Arthrex Company Information
Table 136. Arthrex Description and Business Overview
Table 137. Arthrex Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. Arthrex Spine Biologics Product
Table 139. Arthrex Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Spine Biologics Distributors List
Table 143. Spine Biologics Customers List
Table 144. Spine Biologics Market Trends
Table 145. Spine Biologics Market Drivers
Table 146. Spine Biologics Market Challenges
Table 147. Spine Biologics Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
Table 151. Authors List of This Report
List of Figures
Figure 1. Product Picture of Spine Biologics
Figure 2. Global Spine Biologics Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Spine Biologics Market Share by Type: 2024 & 2031
Figure 4. Bone Graft Product Picture
Figure 5. Bone Graft Substitute Product Picture
Figure 6. Platelet Rich Plasma (PRP) Product Picture
Figure 7. BMAC (Bone Marrow Aspirate Concentrate) Product Picture
Figure 8. Global Spine Biologics Market Value by Application (2020-2031) & (US$ Million)
Figure 9. Global Spine Biologics Market Share by Application: 2024 & 2031
Figure 10. Anterior Cervical Discectomy and Fusion
Figure 11. Posterior Lumbar Interbody Fusion
Figure 12. Others
Figure 13. Global Spine Biologics Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Spine Biologics Market Size (2020-2031) & (US$ Million)
Figure 15. Global Spine Biologics Sales (2020-2031) & (K Units)
Figure 16. Global Spine Biologics Average Price (USD/Unit) & (2020-2031)
Figure 17. Spine Biologics Report Years Considered
Figure 18. Spine Biologics Sales Share by Manufacturers in 2024
Figure 19. Global Spine Biologics Revenue Share by Manufacturers in 2024
Figure 20. Global 5 and 10 Largest Spine Biologics Players: Market Share by Revenue in Spine Biologics in 2024
Figure 21. Spine Biologics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Global Spine Biologics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 23. North America Spine Biologics Sales Market Share by Country (2020-2031)
Figure 24. North America Spine Biologics Revenue Market Share by Country (2020-2031)
Figure 25. U.S. Spine Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Canada Spine Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Europe Spine Biologics Sales Market Share by Country (2020-2031)
Figure 28. Europe Spine Biologics Revenue Market Share by Country (2020-2031)
Figure 29. Germany Spine Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. France Spine Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. U.K. Spine Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Italy Spine Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Russia Spine Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Asia Pacific Spine Biologics Sales Market Share by Region (2020-2031)
Figure 35. Asia Pacific Spine Biologics Revenue Market Share by Region (2020-2031)
Figure 36. China Spine Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Japan Spine Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. South Korea Spine Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. India Spine Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Australia Spine Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. China Taiwan Spine Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Indonesia Spine Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Thailand Spine Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Malaysia Spine Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Latin America Spine Biologics Sales Market Share by Country (2020-2031)
Figure 46. Latin America Spine Biologics Revenue Market Share by Country (2020-2031)
Figure 47. Mexico Spine Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Brazil Spine Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Argentina Spine Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Middle East and Africa Spine Biologics Sales Market Share by Country (2020-2031)
Figure 51. Middle East and Africa Spine Biologics Revenue Market Share by Country (2020-2031)
Figure 52. Turkey Spine Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Saudi Arabia Spine Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. UAE Spine Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Global Sales Market Share of Spine Biologics by Type (2020-2031)
Figure 56. Global Revenue Market Share of Spine Biologics by Type (2020-2031)
Figure 57. Global Spine Biologics Price (USD/Unit) by Type (2020-2031)
Figure 58. Global Sales Market Share of Spine Biologics by Application (2020-2031)
Figure 59. Global Revenue Market Share of Spine Biologics by Application (2020-2031)
Figure 60. Global Spine Biologics Price (USD/Unit) by Application (2020-2031)
Figure 61. Spine Biologics Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which region is expected to have the highest market share?
For each regional market, the report conducted in-depth comparative analysis from multiple dimensions such as market size, 3.3% compound annual growth rate, market demand, industrial structure, policy environment, and the layout of major enterprises. It systematically summarized the market characteristics and competitive environment of different regions. At the same time, it also focused on analyzing the demand structure, market growth drivers, and investment environment of each region, providing valuable references for enterprises to identify key regional markets, formulate global market layouts and sales strategies.
What was the global market size of Spine Biologics in 2025?
Which companies rank high in the global Spine Biologics market?
What is the annual compound growth rate of the global Spine Biologics market size from 2025 to 2031?
What was the global market size of Spine Biologics in 2031?
Related Reports
Global Spine Biologics Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Spine Biologics market is projected to grow from US$ 2595 million in 2025 to US$ 3864 million by 2032, at a CAGR of 6.3% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-07-11
Pages: 169
USD 4900.00
(Single User License)
Global Spine Biologics Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Spine Biologics market size was US$ 2595 million in 2025 and is forecast to reach a readjusted size of US$ 3864 million by 2032 with a CAGR of 6.3% during the forecast period 2026-2032.
Published Date: 2026-07-11
Pages: 137
USD 4250.00
(Single User License)
Global Spine Biologics Market Research Report 2026
The global Spine Biologics market was valued at US$ 2595 million in 2025 and is anticipated to reach US$ 3864 million by 2032, at a CAGR of 6.3% from 2026 to 2032.
Published Date: 2026-07-11
Pages: 121
USD 2900.00
(Single User License)
Spine Biologics- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Spine Biologics was estimated to be worth US$ 2595 million in 2025 and is projected to reach US$ 3864 million, growing at a CAGR of 6.3% from 2026 to 2032.
Published Date: 2026-07-11
Pages: 142
USD 3950.00
(Single User License)
Global Spine Biologics Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Spine Biologics market is projected to grow from US$ 2520 million in 2024 to US$ 3153 million by 2031, at a CAGR of 3.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 164
USD 4900.00
(Single User License)
Global Spine Biologics Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Spine Biologics was estimated to be worth US$ 2520 million and is forecast to reach approximately US$ 3153 million by 2031 with a CAGR of 3.3% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 152
USD 5900.00
(Single User License)
Global Spine Biologics Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Spine Biologics market size was US$ 2520 million in 2024 and is forecast to a readjusted size of US$ 3153 million by 2031 with a CAGR of 3.3% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 97
USD 4250.00
(Single User License)
Spine Biologics- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Spine Biologics was estimated to be worth US$ 2520 million in 2024 and is forecast to a readjusted size of US$ 3153 million by 2031 with a CAGR of 3.3% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 121
USD 3950.00
(Single User License)
Global Spine Biologics Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Spine biologics are used in spine surgery as lieu allografts and as support for bones in and around the spinal region. They can also be used as products that can cure the spine injuries or disorders or degenerated discs.
Published Date: 2024-04-17
Pages: 161
USD 5600.00
(Single User License)
Global Spine Biologics Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Spine biologics are used in spine surgery as lieu allografts and as support for bones in and around the spinal region. They can also be used as products that can cure the spine injuries or disorders or degenerated discs.
Published Date: 2024-04-16
Pages: 150
USD 5900.00
(Single User License)
Global Spine Biologics Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Spine Biologics market is projected to grow from US$ 2595 million in 2025 to US$ 3864 million by 2032, at a CAGR of 6.3% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-07-11
Pages: 169
USD 4900.00 (Single User License)Global Spine Biologics Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Spine Biologics market size was US$ 2595 million in 2025 and is forecast to reach a readjusted size of US$ 3864 million by 2032 with a CAGR of 6.3% during the forecast period 2026-2032.
Published: 2026-07-11
Pages: 137
USD 4250.00 (Single User License)Global Spine Biologics Market Research Report 2026
The global Spine Biologics market was valued at US$ 2595 million in 2025 and is anticipated to reach US$ 3864 million by 2032, at a CAGR of 6.3% from 2026 to 2032.
Published: 2026-07-11
Pages: 121
USD 2900.00 (Single User License)Spine Biologics- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Spine Biologics was estimated to be worth US$ 2595 million in 2025 and is projected to reach US$ 3864 million, growing at a CAGR of 6.3% from 2026 to 2032.
Published: 2026-07-11
Pages: 142
USD 3950.00 (Single User License)Global Spine Biologics Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Spine Biologics market is projected to grow from US$ 2520 million in 2024 to US$ 3153 million by 2031, at a CAGR of 3.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 164
USD 4900.00 (Single User License)Global Spine Biologics Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Spine Biologics was estimated to be worth US$ 2520 million and is forecast to reach approximately US$ 3153 million by 2031 with a CAGR of 3.3% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 152
USD 5900.00 (Single User License)Global Spine Biologics Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Spine Biologics market size was US$ 2520 million in 2024 and is forecast to a readjusted size of US$ 3153 million by 2031 with a CAGR of 3.3% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 97
USD 4250.00 (Single User License)Spine Biologics- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Spine Biologics was estimated to be worth US$ 2520 million in 2024 and is forecast to a readjusted size of US$ 3153 million by 2031 with a CAGR of 3.3% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 121
USD 3950.00 (Single User License)Global Spine Biologics Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Spine biologics are used in spine surgery as lieu allografts and as support for bones in and around the spinal region. They can also be used as products that can cure the spine injuries or disorders or degenerated discs.
Published: 2024-04-17
Pages: 161
USD 5600.00 (Single User License)Global Spine Biologics Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Spine biologics are used in spine surgery as lieu allografts and as support for bones in and around the spinal region. They can also be used as products that can cure the spine injuries or disorders or degenerated discs.
Published: 2024-04-16
Pages: 150
USD 5900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 2900.00
USD 4350.00
USD 5800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
REPORT SCOPE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now